Drugs / S6G5T-1
last change Oct 2017 re-read 2 minutes ago

S6G5T-1

Developed for
acne
Investigated by
Accelovance · Sol-Gel Technologies, Ltd.

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02661958 May 2016 → Oct 2017 acne Sol-Gel Technologies, Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as S6G5T-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02661958
Route Topical “once a day topical cream” NCT02661958